Metsera, Inc.
Why Robinhood?
You can watch Metsera, Inc. and buy or sell other stocks, ETFs, and their options commission-free!About MTSR
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
MTSR Key Statistics
Stock Snapshot
With a market cap of 7.41B, Metsera, Inc.(MTSR) trades at $70.50. The stock has a price-to-earnings ratio of -23.55.
On 2026-03-23, Metsera, Inc.(MTSR) stock opened at —, reached a high of —, and a low of —.
The Metsera, Inc.(MTSR)'s current trading volume is 0, compared to an average daily volume of 4.34M.
During the past year, Metsera, Inc.(MTSR) stock moved between $12.30 at its lowest and $83.86 at its peak.
During the past year, Metsera, Inc.(MTSR) stock moved between $12.30 at its lowest and $83.86 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.